At 20.3x earnings and 16.9x forward earnings, DRI is priced like a stable compounder, not a distressed cyclical, yet the balance sheet tells a more cautious story. The Altman Z-Score of 2.4 sits in the grey zone, signaling moderate financial stress risk rather than fortress-level safety, and the 0.4 current ratio reinforces liquidity tightness. A PEG Forward of 2.1 suggests investors are paying a premium relative to growth, especially with EPS Next Year estimated at $9.54 versus current EPS of 14.10. This is not a screaming bargain; it’s a quality operator trading at a reasonable but not discounted multiple, with valuation dependent on execution rather than margin of safety.